Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30150% above fair value
$26.35−1.45 (-5.22%)
Close on Nov 12, 2026Market cap $1.01BP/E –Yield –
Ceribell profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ceribell's profit margin for the twelve months ending Jun 30, 2026 was -64.7%. For fiscal 2025 it was -60.0%, against -61.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -60.0% | +1.8 |
| FY2024 | Dec 31, 2024 | -61.8% | +3.3 |
| FY2023 | Dec 31, 2023 | -65.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -68.6% | −4.2 |
| Q1 FY2026 | Mar 31, 2026 | -74.5% | −12.1 |
| Q4 FY2025 | Dec 31, 2025 | -54.6% | +13.3 |
| Q3 FY2025 | Sep 30, 2025 | -59.6% | +1.0 |
| Q2 FY2025 | Jun 30, 2025 | -64.4% | −6.0 |
| Q1 FY2025 | Mar 31, 2025 | -62.4% | −3.2 |
| Q4 FY2024 | Dec 31, 2024 | -67.9% | −4.8 |
| Q3 FY2024 | Sep 30, 2024 | -60.6% | +0.2 |
| Q2 FY2024 | Jun 30, 2024 | -58.4% | – |
| Q1 FY2024 | Mar 31, 2024 | -59.2% | – |
| Q4 FY2023 | Dec 31, 2023 | -63.0% | – |
| Q3 FY2023 | Sep 30, 2023 | -60.8% | – |
See a number that looks wrong?